Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients

Conclusion: bedaquiline-containing regimens appear to show reassuring safety profile with low frequency of serious adverse reactions.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Galstyan, A., Borisov, S., Sinitsyn, M., Ivanova, D., Slogodskay, L. Tags: Tuberculosis Source Type: research